NCT01756430View on ClinicalTrials.gov

Efficacy and Safety of Carvedilol SR Versus Carvedilol IR in Patients With Essential Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

238

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Hypertension
Interventions
DRUG

Carvedilol SR 32mg, QD

"* Carvedilol SR 32mg QD for 4 weeks~* With the others investigation product placebo 1 capsule QD and 1 tablet BID for 4 weeks."

DRUG

Carvedilol SR 64mg, QD

"* Carvedilol SR 64mg QD for 4 weeks~* With the others investigation product placebo 1 capsule QD and 1 tablet BID for 4 weeks."

DRUG

Carvedilol IR 25mg, QD

"* Carvedilol IR 25mg QD for 4 weeks~* With the others investigation product placebo 2 capsules and 1 tablet QD for 4 weeks."

DRUG

Carvedilol IR 25mg, BID

"* Carvedilol IR 25mg BID for 4 weeks~* With the others investigation product placebo 2 capsules QD for 4 weeks."

Trial Locations (1)

471-701

The Hanyang Universitiy Guri Hospital, Guri-si

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY